Xylem Inc. (NYSE:XYL) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Xylem Inc. (NYSE:XYLGet Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $153.3077.

A number of research analysts have recently commented on the stock. Citigroup cut their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Royal Bank Of Canada lifted their target price on Xylem from $157.00 to $159.00 and gave the stock an “outperform” rating in a research report on Thursday. Barclays lowered their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. CLSA raised Xylem to a “hold” rating in a report on Thursday, June 25th. Finally, Weiss Ratings downgraded Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th.

Read Our Latest Report on XYL

Xylem Trading Down 1.9%

Shares of XYL stock opened at $122.96 on Friday. Xylem has a 1 year low of $105.29 and a 1 year high of $154.27. The firm’s fifty day simple moving average is $113.23 and its 200 day simple moving average is $123.48. The firm has a market capitalization of $29.23 billion, a P/E ratio of 30.59, a price-to-earnings-growth ratio of 1.78 and a beta of 1.03. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business’s revenue was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts predict that Xylem will post 5.51 EPS for the current year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date was Thursday, May 28th. Xylem’s dividend payout ratio is presently 42.79%.

Insider Buying and Selling at Xylem

In other Xylem news, Director Jerome A. Peribere purchased 1,210 shares of the stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. This represents a 4.65% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. 0.32% of the stock is owned by company insiders.

Institutional Trading of Xylem

A number of institutional investors and hedge funds have recently added to or reduced their stakes in XYL. J. Stern & Co. LLP grew its holdings in shares of Xylem by 12,326.6% in the 4th quarter. J. Stern & Co. LLP now owns 45,448,168 shares of the industrial products company’s stock worth $6,189,132,000 after purchasing an additional 45,082,435 shares during the last quarter. Norges Bank bought a new position in Xylem during the 4th quarter valued at about $361,012,000. SEB Asset Management AB bought a new position in Xylem during the 1st quarter valued at about $66,700,000. Balyasny Asset Management L.P. boosted its position in Xylem by 346.2% in the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock valued at $105,160,000 after buying an additional 553,152 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new position in Xylem in the second quarter valued at about $64,407,000. Institutional investors own 87.96% of the company’s stock.

Xylem Company Profile

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Further Reading

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.